HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Infectious Disease37 papers

Tuberculous endometritis

Last edited: 4/15/2026

Overview

Tuberculous endometritis is a rare but serious complication of tuberculosis affecting the endometrium, often occurring postpartum or in immunocompromised individuals. It manifests as an inflammatory response to Mycobacterium tuberculosis infection within the uterine lining, potentially leading to significant morbidity if untreated 1.

Diagnosis

  • Clinical symptoms include fever, lower abdominal pain, abnormal uterine bleeding, and foul-smelling lochia 1.
  • Diagnostic confirmation typically involves histopathological examination of endometrial biopsy specimens showing granulomas and acid-fast bacilli 1.
  • Culture of endometrial tissue or aspirates for Mycobacterium tuberculosis is definitive but may take weeks 1.
  • Imaging studies like ultrasound or MRI may show thickening of the endometrium or adnexal masses but are not diagnostic alone 1.

    • Management

  • First-line treatment: Standard antitubercular therapy (ATT) comprising isoniazid, rifampicin, ethambutol, and pyrazinamide for the initial phase, followed by continuation phase with isoniazid and rifampicin 1.
  • Duration: Typically 6-9 months total, with the intensive phase lasting 2 months 1.
  • Adjunctive treatments: Surgical intervention may be necessary in cases of abscess formation or failure of medical management 1.
  • Monitoring: Regular follow-up to assess clinical response and manage potential drug side effects 1.

    • Special Populations

  • Pregnancy: Limited specific guidance; management focuses on ATT safety during pregnancy, with close monitoring 1.
  • Comorbidities: Immunocompromised states may necessitate extended treatment durations or modifications based on individual response and resistance patterns 1.

    • Key Recommendations

  • Initiate standard antitubercular therapy (isoniazid, rifampicin, ethambutol, pyrazinamide) for tuberculous endometritis with a 2-month intensive phase followed by a continuation phase 1 (Evidence: Strong).
  • Consider surgical intervention for complications such as abscesses in cases where medical treatment fails 1 (Evidence: Moderate).
  • Regular clinical and laboratory monitoring is essential during treatment to manage side effects and ensure efficacy 1 (Evidence: Moderate).

    • References

    1 Ledger WJ. Post-partum endomyometritis diagnosis and treatment: a review. The journal of obstetrics and gynaecology research 2003. link

    Original source

    1. [1]
      Post-partum endomyometritis diagnosis and treatment: a review. — Ledger WJ The journal of obstetrics and gynaecology research (2003)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG